AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇲🇼
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE in Malawi
1 product registered with PMRA — 0 active, 1 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DOLUTEGRAVIR_LAMIVUDINE_AND_TENOFOVIR_DISOPROXIL_FUMARATE 50/300/300MG TABLET TABLET | PMPB/PL297/29 | — | expired | 31 Mar 2025 |
DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE — PMRA Registration Details
PMRA (Malawi) has 1 registered product containing DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.
Track DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.